https://www.vpulsehk.com/hepatology-1/hcv-micro-elimination-in-hong-kong-insights-from-aasld-the-liver-meeting 2026-04-13 https://www.vpulsehk.com/hepatology-1/treatment-on-antibiotic-resistance-in-helicobacter-pylori 2026-04-13 https://www.vpulsehk.com/hepatology-1/the-9th-annual-scientific-meeting-of-the-hong-kong-society-of-hepatobiliary-and-pancreatic-surgery 2026-04-13 https://www.vpulsehk.com/hepatology-1/poems-syndrome-%E2%80%93-a-rare-and-challenging-disorder 2026-04-13 https://www.vpulsehk.com/hepatology-1/switching-for-a-better-renal-outcome-in-the-management-of-chronic-hepatitis-b 2026-04-13 https://www.vpulsehk.com/hepatology-1/hepatocellular-carcinoma-a-disease-with-ethnic-geographic-differences 2026-04-13 https://www.vpulsehk.com/hepatology-1/are-we-doing-our-best-to-reduce-the-risk-of-hcc-in-hbv-patients 2026-04-13 https://www.vpulsehk.com/hepatology-1/advancing-hcv-elimination-in-marginalised-communities-strategies-and-challenges 2026-04-13 https://www.vpulsehk.com/hepatology-1/mitigating-hcc-risk-through-managing-hbv-infection-%E2%80%93-the-insights-from-the-updated-easl-guidelines 2026-04-13 https://www.vpulsehk.com/hepatology-1/entecavir-teva 2026-04-13 https://www.vpulsehk.com/hepatology-1/hepwin%C2%AE 2026-04-13